Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028 ...Middle East

SAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today announced the pricing of $625.0 million aggregate principal amount of convertible senior notes due 2028...

Hence then, the article about halozyme therapeutics inc announces upsize and pricing of private offering of 625 million of convertible senior notes due 2028 was published today ( Tuesday 16/08/2022 - 05:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028 )

Also on site :

• Taiwan’s economy is booming thanks to AI. Not everyone sees the benefits
• Amazon’s 2-Pack of 'Light and Airy' Tank Tops Is Just $8 and 'Perfect for Summer'
• SXSW London: Michelle Obama, Claire Foy and Piers Morgan Among Latest Speakers Added to Fest Lineup